Skip to main content
Clinical Trials/NCT03277417
NCT03277417
Unknown
Not Applicable

Does the Amniotic Fluid Index Affect the Fetal Cardiac Performance?

Hillel Yaffe Medical Center1 site in 1 country90 target enrollmentSeptember 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Oligohydramnios
Sponsor
Hillel Yaffe Medical Center
Enrollment
90
Locations
1
Primary Endpoint
Fetal cardiac ventricles
Last Updated
8 years ago

Overview

Brief Summary

To evaluate and compare fetal cardiac performance by fetal echocardiography and delivery outcome between fetuses with isolated oligohydramnios, normal amniotic fluid and polyhydramnios.

Registry
clinicaltrials.gov
Start Date
September 2017
End Date
September 2019
Last Updated
8 years ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Gestational age 24-42 weeks
  • Singleton pregnancies

Exclusion Criteria

  • Fetal anatomical or chromosomal abnormality
  • Known fetal cardiac defect
  • Suspected fetal infection
  • Suspected IUGR

Outcomes

Primary Outcomes

Fetal cardiac ventricles

Time Frame: One month

The width of the fetal cardiac ventricles will be measured and compared between all three groups

Secondary Outcomes

  • Gestational age(One month)
  • Mode of delivery(One month)
  • Birth weight(One month)

Study Sites (1)

Loading locations...

Similar Trials